Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BI 113823 in Healthy Male Volunteers
NCT02259972Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2010
- Primary completion
- Jun 2010
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of BI 113823 in osteoarthritis (OA) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Number of participants with clinically significant findings on physical examination, Number of participants with clinically significant findings in vital signs and 4 more. Started Jan 2010; status: completed.
02
Drugs
BI 113823
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02259972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259972.